DMNoMore is dedicated to the eradication of Type 1 Diabetes through a range of new medicines and strategies. The company is developing a range of novel therapeutic innovations including an exciting new vaccine to treat and prevent diabetes and a predictive kit for first-degree relatives. Our long-term goal is the broadening of our platform approach to other autoimmune diseases through our active R & D programme.
We are committed to ensuring that there will be equitable access to all our innovations and products globally. This will be achieved through close association with our sister charitable foundation: DiamEND Foundation www.diamendfoundation.org